Introduction Recent studies have reported that HbA1c and lipid variability is useful for risk
stratification in diabetes mellitus. The present study evaluated the predictive value of the …

Introduction Emerging evidence suggests that HbA1c variability, in addition to HbA1c itself,
can be used as a predictor for mortality. The present study aims to examine the predictive …

Aim To examine the associations between variability in lipids and the risk of cardiovascular
disease (CVD) and mortality in patients with type 2 diabetes based on low‐density …

Aims We aimed to evaluate the association between HbA1c variability and mortality due to
all causes, cancer, and non-cancer in patients with type 2 diabetes independently of mean …

Background In type 2 diabetes, tight glycaemic control lowers the risk of diabetic
complications, but it remains uncertain whether variability of glycaemia influences outcomes …

OBJECTIVE Glycemic variability is emerging as a measure of glycemic control, which may
be a reliable predictor of complications. This systematic review and meta-analysis evaluates …

Objective We assessed the relationship of mortality with glycated hemoglobin (HbA1c)
variability and with absolute change in HbA1c. Design A population-based prospective …

Introduction The present study evaluated the application of incorporating non‐linear J/U‐
shaped relationships between mean HbA1c and cholesterol levels into risk scores for …

Introduction: Diabetes is often accompanied by undiagnosed dyslipidemia. The aim of the
study is to investigate the clinical relevance of lipid profiles and lipid ratios as predictive …

Background HbA1c variability has emerged as risk factor for cardiovascular diseases in
diabetes. However, the impact of HbA1c variability on cardiovascular diseases in subjects …